Teleflex Stock Forecast, Price & News

Teleflex (NYSE:TFX) Frequently Asked Questions

Is Teleflex a buy right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last twelve months. There are currently 1 hold rating and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Teleflex stock.
View analyst ratings for Teleflex or view top-rated stocks.

What stocks does MarketBeat like better than Teleflex?

Wall Street analysts have given Teleflex a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Teleflex wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Teleflex?

Teleflex saw a decrease in short interest in the month of August. As of August 31st, there was short interest totaling 520,900 shares, a decrease of 38.7% from the August 15th total of 849,200 shares. Based on an average trading volume of 335,800 shares, the short-interest ratio is currently 1.6 days. Currently, 1.1% of the shares of the stock are short sold.
View Teleflex's Short Interest.

When is Teleflex's next earnings date?

Teleflex is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Teleflex.

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) announced its quarterly earnings results on Thursday, July, 29th. The medical technology company reported $3.35 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $2.87 by $0.48. The medical technology company earned $713.47 million during the quarter, compared to analysts' expectations of $680.85 million. Teleflex had a net margin of 13.06% and a trailing twelve-month return on equity of 17.29%. During the same period last year, the business earned $1.93 EPS.
View Teleflex's earnings history.

How has Teleflex's stock been impacted by Coronavirus (COVID-19)?

Teleflex's stock was trading at $342.08 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, TFX stock has increased by 13.4% and is now trading at $387.95.
View which stocks have been most impacted by COVID-19.

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex declared a quarterly dividend on Thursday, July 29th. Investors of record on Monday, August 16th will be given a dividend of $0.34 per share on Wednesday, September 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.35%. The ex-dividend date of this dividend is Friday, August 13th.
View Teleflex's dividend history.

Is Teleflex a good dividend stock?

Teleflex pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.35%. Teleflex does not yet have a strong track record of dividend growth. The dividend payout ratio of Teleflex is 12.75%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Teleflex will have a dividend payout ratio of 9.32% next year. This indicates that Teleflex will be able to sustain or increase its dividend.
View Teleflex's dividend history.

What guidance has Teleflex issued on next quarter's earnings?

Teleflex updated its FY 2021 earnings guidance on Thursday, August, 5th. The company provided earnings per share (EPS) guidance of $12.900-$13.100 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $12.750. The company issued revenue guidance of $2.80 billion-$2.84 billion, compared to the consensus revenue estimate of $2.82 billion.

What price target have analysts set for TFX?

10 Wall Street analysts have issued twelve-month price objectives for Teleflex's stock. Their forecasts range from $415.00 to $486.00. On average, they anticipate Teleflex's share price to reach $455.80 in the next twelve months. This suggests a possible upside of 17.5% from the stock's current price.
View analysts' price targets for Teleflex or view top-rated stocks among Wall Street analysts.

Who are Teleflex's key executives?

Teleflex's management team includes the following people:

• Liam J. Kelly, Chairman, President & Chief Executive Officer
• Thomas E. Powell, Chief Financial Officer & Executive Vice President
• Timothy F. Duffy, Chief Information Officer & Vice President
• Michelle Fox, Chief Medical Officer & Vice President
• Gwen Chapman, Chief Compliance Officer & Vice President

What is Liam Kelly's approval rating as Teleflex's CEO?

73 employees have rated Teleflex CEO Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among Teleflex's employees.

Who are some of Teleflex's key competitors?

Some companies that are related to Teleflex include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Boston Scientific (BSX), IDEXX Laboratories (IDXX), DexCom (DXCM), Baxter International (BAX), ResMed (RMD), STERIS (STE), Insulet (PODD), Hologic (HOLX) and Abiomed (ABMD).
View all of TFX's competitors.

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), salesforce.com (CRM) and Cisco Systems (CSCO).

What is Teleflex's stock symbol?

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

Who are Teleflex's major shareholders?

Teleflex's stock is owned by a variety of retail and institutional investors. Top institutional investors include Price T Rowe Associates Inc. MD (12.12%), Vanguard Group Inc. (10.62%), BlackRock Inc. (10.54%), State Street Corp (3.99%), American Century Companies Inc. (2.81%) and Marshall Wace LLP (1.96%). Company insiders that own Teleflex stock include Benson Smith, Cameron P Hicks, James J Leyden, John Deren, Liam Kelly, Stephen K MD Klasko, Stuart A Randle and Thomas E Powell.
View institutional ownership trends for Teleflex.

Which major investors are selling Teleflex stock?

TFX stock was sold by a variety of institutional investors in the last quarter, including American Century Companies Inc., Mar Vista Investment Partners LLC, BlackRock Inc., APG Asset Management N.V., Atlanta Capital Management Co. L L C, Nuveen Asset Management LLC, William Blair Investment Management LLC, and Invesco Ltd.. Company insiders that have sold Teleflex company stock in the last year include Cameron P Hicks, Liam Kelly, Stephen K MD Klasko, and Stuart A Randle.
View insider buying and selling activity for Teleflex or view top insider-selling stocks.

Which major investors are buying Teleflex stock?

TFX stock was purchased by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, FMR LLC, JPMorgan Chase & Co., Amundi, Marshall Wace LLP, Citadel Advisors LLC, Kimelman & Baird LLC, and Woodline Partners LP.
View insider buying and selling activity for Teleflex or or view top insider-buying stocks.

How do I buy shares of Teleflex?

Shares of TFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Teleflex's stock price today?

One share of TFX stock can currently be purchased for approximately $387.95.

How much money does Teleflex make?

Teleflex has a market capitalization of $18.16 billion and generates $2.54 billion in revenue each year. The medical technology company earns $335.32 million in net income (profit) each year or $10.67 on an earnings per share basis.

How many employees does Teleflex have?

Teleflex employs 14,000 workers across the globe.

When was Teleflex founded?

Teleflex was founded in 1943.

What is Teleflex's official website?

The official website for Teleflex is www.teleflex.com.

Where are Teleflex's headquarters?

Teleflex is headquartered at 550 E SWEDESFORD RD, WAYNE PA, 19087.

How can I contact Teleflex?

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The medical technology company can be reached via phone at (610) 225-6800 or via email at [email protected].